JezK
Edit File: 1647497941.M954182P22773.mocha3025.mochahost.com,S=14830,W=15108:2,S
Received: from mocha3025.mochahost.com by mocha3025.mochahost.com with LMTP id kFugMuwH3V3D6A4AaMJ/gg (envelope-from <nasir.tokhi123@gmail.com>); Tue, 26 Nov 2019 06:09:32 -0500 Received: from mail-pg1-f195.google.com ([209.85.215.195]:38781) by mocha3025.mochahost.com with esmtps (TLSv1.2:ECDHE-RSA-AES128-GCM-SHA256:128) (Exim 4.92) (envelope-from <nasir.tokhi123@gmail.com>) id 1iZYiq-005H7g-KW; Tue, 26 Nov 2019 06:09:32 -0500 Received: by mail-pg1-f195.google.com with SMTP id t3so8383487pgl.5; Tue, 26 Nov 2019 03:07:32 -0800 (PST) Return-Path: <nasir.tokhi123@gmail.com> From: "Dr.Nasir Ahmad tokhi" <nasir.tokhi123@gmail.com> To: "Khairullah Naderi" <khairullahnaderi@gmail.com>, "Dr.Hafizullah Khalilzoey" <dr_hafizullah@yahoo.com> Cc: "Dr. Nasir Ahmad Tokhi" <dr.tokhi@jack.af>, <dr.tokhi@jack.ngo>, <dr.zia@jack.ngo>, <haroon.mahmoodi@jack.af>, "Mohammad Haroon Mahmoodi" <jack.kdz.pharmacy@gmail.com>, <ghaznawi@jack.ngo>, <mirzaee@jack.ngo>, <Mirzaee@jack.af>, "Sardar Wali Takal" <takal@jack.ngo>, =?utf-8?Q?=E2=80=8BNoor_Ahmad?= <ahmad@jack.ngo>, "sultan rasoolzai" <sultanrasoolzai@gmail.com>, <fraidon@jack.af> References: <CAPkiFa2M1LuXRSqEb+5f-KFKVuA9cJ5ExvwEoOQtCNzf0JgA5w@mail.gmail.com> In-Reply-To: <CAPkiFa2M1LuXRSqEb+5f-KFKVuA9cJ5ExvwEoOQtCNzf0JgA5w@mail.gmail.com> Subject: Re: ANTI-LASHMANIASIS PRODUCT REQUEST FORM FROM kdz JACK OFFICE Date: Tue, 26 Nov 2019 15:37:01 +0430 Message-ID: <CAJX2XaK_jDptwTneTPLuJCu5xxxRH+Ep=N=o5fLouGmOC23XqQ@mail.gmail.com> MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_000_2163B_01D839EC.9CA936B0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHwRqpADYEQsRBT0b56Eg59wnb5kwLB8aIG X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=x-gm-message-state:mime-version:references:in-reply-to:from:date :message-id:subject:to:cc; bh=5R/d18OqKpCcwP1YAXoUPy+oa0MnaypSdu4Y8OUYOAM=; b=ZUTSVvJhNazMP8/nRTZQpE/jIIUdlxjkvVZ+IVAMDFB7zU6vzxKoic/k7q4pJukvMg o8iIE3Qi688qc1/k4oG/eEEuY5rnFo5fBwiRxOC805QcyKWRtmhD27xs/fQYMnjF+nLp XwFK4fVfc4lEB0NklOltkR2Cpzw2gPrpxlY8Wn22XDsriKVbByXLQy6UUvjvBVeNuL4d QVf+2yDYmCml42FNQ8ENP4cX34NULbxPMiNcUCANjC0e0pHjP2UXCAWSEDsgPrXGijF7 tnaAbcsrYnb4dRgyhsvC+erm/7DiuH7QfcnMGdw4APtyi08toep/825OqUaQjZ7uy9Z8 HgYg== X-Gm-Message-State: APjAAAWyrH4c44MwbAnMmGUDXbOTAIWKg3HN+46/o2l/5SXuB6u3Rih7 2TesKZV2h+G7hNHG+VL+GpLX1RZrAX6xxfUrITQ= X-Google-Smtp-Source: APXvYqyqKd2VfV7TcI1q4qt9jIk0rWWd9QlN7PR2mfmnfcLyq+3aTHLPZQIYVbURb2GT08pvW2Uky7OPk0+0APgCFcY= X-Received: by 2002:a65:438b:: with SMTP id m11mr37379195pgp.388.1574766431584; Tue, 26 Nov 2019 03:07:11 -0800 (PST) X-OlkEid: 000000005FCBC13F93E5A7478B89D20520A2ADCA0700C3B68E10F77511CEB4CD00AA00BBB6E600000000000C00005699424C4FF4794B83FDE3A0EC83835900000000089B0000E5B4BA480B6DCA4C9F45BA512DE076C1 This is a multipart message in MIME format. ------=_NextPart_000_2163B_01D839EC.9CA936B0 Content-Type: multipart/alternative; boundary="----=_NextPart_001_2163C_01D839EC.9CA936B0" ------=_NextPart_001_2163C_01D839EC.9CA936B0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 7bit Dear Khairullah Naderi Thank you for you request below point is import to be clear . 1. clarify the closing balance of Anti Malaria Vial/Amp in the last month of the year health facilities wise and stock buffer ? 2.Number of Supplied of Anti Leishmania Vial/Amp (new supplied) 3.please send me the Leishmania Case which were recorded in last year.1397 and 1398 by monthly base and health facilities-wise 4.How many vial/Amp have you been requested? Finally send me the required vial/Amp of Anti Leishmania drug request for six months Best regard, Dr. Nasir Ahmad Tokhi MD, MPH| Malaria Project Manager / P4P and reporting Focal Point | Just for Afghan Capacity and Knowledge (JACK)| Country office Kabul| Tel: +93(0)705546907 - +93(0)799612015 | dr.tokhi@jack.af <mailto:dr.tokhi@jack.af> | www.jack.af <http://www.jack.af> On Tue, Nov 26, 2019 at 2:50 PM Khairullah Naderi <khairullahnaderi@gmail.com <mailto:khairullahnaderi@gmail.com> > wrote: Dear Dr. Sahib Tokhi! Attached please find, anti-leishmaniasis drug request sheet form Kunudz for 16 HFs for sex months kindly share with the related department, now these days we faces to the shortage of anti-Leishmania in health HFs also we have a lot of cases. BR Naderi ------=_NextPart_001_2163C_01D839EC.9CA936B0 Content-Type: text/html; boundary="000000000000c2627805983de1bc"; charset="utf-8" Content-Transfer-Encoding: quoted-printable <div dir=3D"ltr"><div class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">Dear Khairullah = Naderi</div><div class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">Thank you for you = request below point is import to be clear .</div><div = class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">1. clarify the closing = balance of Anti Malaria Vial/Amp in the last month of=C2=A0 the year = health facilities wise and stock buffer ?</div><div = class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">2.Number of Supplied = of Anti Leishmania Vial/Amp (new supplied)</div><div = class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">3.please send me the = Leishmania Case which were recorded in last year.1397 and 1398 by = monthly base and health facilities-wise</div><div = class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">4.How many vial/Amp = have you been requested?</div><div class=3D"gmail_default" = style=3D"font-family:georgia,serif;color:#45818e">Finally=C2=A0send me = the required vial/Amp of Anti Leishmania drug request for six = months</div><div><div dir=3D"ltr" class=3D"gmail_signature" = data-smartmail=3D"gmail_signature"><div dir=3D"ltr"><div><div = dir=3D"ltr"><div><div dir=3D"ltr"><div><div dir=3D"ltr"><p = class=3D"MsoNormal"><span style=3D"color:rgb(31,73,125)">Best = regard,<u></u><u></u></span></p><p class=3D"MsoNormal"><u></u></p><table = align=3D"left" cellspacing=3D"0" cellpadding=3D"0"><tbody><tr><td = width=3D"1" height=3D"12"></td></tr><tr><td></td><td><img = src=3D"cid:image003.png@01D502D3.D8F2E650"></td></tr></tbody></table><p = class=3D"MsoNormal"><b><span = style=3D"color:rgb(31,73,125);font-family:"Calibri = Light",sans-serif;font-size:10.5pt"><br><br></span></b></p><p = class=3D"MsoNormal"><b><span = style=3D"color:rgb(31,73,125);font-family:"Calibri = Light",sans-serif;font-size:10.5pt"><br></span></b></p><p = class=3D"MsoNormal"><b><span = style=3D"color:rgb(31,73,125);font-family:"Calibri = Light",sans-serif;font-size:10.5pt">Dr. Nasir Ahmad Tokhi MD, = MPH</span></b><span style=3D"color:rgb(31,73,125);font-size:10pt">| = Malaria Project Manager / P4P and reporting Focal Point | = </span><b><span style=3D"color:rgb(46,16,176);font-size:10pt">Just for = Afghan Capacity and Knowledge (JACK)</span></b><span = style=3D"color:rgb(31,73,125);font-size:10pt">| Country office = Kabul</span><span = style=3D"color:rgb(31,73,125)">|<span></span></span></p> <p class=3D"MsoNormal"><span style=3D"color:rgb(31,73,125)">Tel: = +93(0)705546907 - +93(0)799612015 | </span><a = href=3D"mailto:dr.tokhi@jack.af" = target=3D"_blank">dr.tokhi@jack.af</a><span = style=3D"color:rgb(31,73,125)"> | </span><a href=3D"http://www.jack.af" = target=3D"_blank">www.jack.af</a><span style=3D"color:rgb(31,73,125)"> = </span><span = style=3D"color:rgb(31,73,125)"><span></span></span></p></div></div></div>= </div></div></div></div></div></div><br></div><br><div = class=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Tue, Nov = 26, 2019 at 2:50 PM Khairullah Naderi <<a = href=3D"mailto:khairullahnaderi@gmail.com">khairullahnaderi@gmail.com</a>= > wrote:<br></div><blockquote class=3D"gmail_quote" = style=3D"margin:0px 0px 0px 0.8ex;border-left:1px solid = rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr">Dear Dr. Sahib = Tokhi!<div><br></div><div>Attached=C2=A0please find, anti-leishmaniasis = drug request sheet form=C2=A0Kunudz for 16 HFs for sex months kindly = share with the related department, now these days we faces to the = shortage of anti-Leishmania in health HFs also we have a lot of = cases.</div><div><br></div><div>BR</div><div>Naderi</div></div> </blockquote></div> ------=_NextPart_001_2163C_01D839EC.9CA936B0-- ------=_NextPart_000_2163B_01D839EC.9CA936B0 Content-Type: image/png; name="image003.png" Content-Transfer-Encoding: base64 Content-ID: <> iVBORw0KGgoAAAANSUhEUgAAAEYAAAA2CAYAAAB6DO9FAAAAAXNSR0IArs4c6QAAAAlwSFlzAAAO xAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAABE/SURBVGhD 1VsLdFTFGZ47d+5md/NYNgRbBK2vUlQkapGKFfVYi5pSpCKgTWuslVeBdsEGeRVIQKLBE6MJBwoS CJhaSosQqbU+W8X6fkNtrdBabW1BSAhJ9nFf/f47e/NO2GQ3Vuecze7enTsz/zff/5wbUVRUxD7v bc+ead9TVd8KyKHatn51Xt6695KVSSQ7wP/7/traacOF8G5WlDRHFssynnr88bkXjxtX8a9k1va5 Bqa6em5GTo61mXO/MIwGxnkaYTHAMCLpyYBC936ugcnONtcIkXOxrn8CURRm2yZezFKUwEN79swq Gz9+XU1fAfpcA2PbtteyHDCcZtsGUxSRBQZdaFlh3ldQPjXG7Nu3TD148PDXGDM+nDBh44d9XXBt 7dwsWJHZjPFrAcLfFEW5wDSbW4Ah1igKZ7HYkRj6vNrdPI8/Pi07FhMFtu3/oqI07wWzHgHDMKb2 LdvGACzyxKfCGIByOhzGM4x5D9fWzl4L4Z4j7nPO1GhUNE+aVPFyT2BVV1/iLSj4UwTATvN4Bq02 TcjNlLGWFYGxjTpq1No0fNQJ/A86jllTc6MnM3PgLFiQuaqafqaqCoAYuWX37h89oShqvhABZhj1 H9i2GNVvwOzaNeMbiuIbb1kxGEV2OSb24DWEsYzVltXkrNk0OdM0xQRYJZZlwYuoQ44dU+4qKKhw OtTWzjrPttXvZ2f783btyi0DAAHDMHHf8TYytwWFLnsAVvjNiRMrmjsCk5GRXamqA6cRoIZBY1hg mOckzr35pIamaeCaMQfq+HS/AAOBRiqK9piqZgnODVBdx2JpnTSxpLvbQF1VUfxLOVeYqnpZIHBE 1NQsW+H3H1mO7yEs2kcCQDU24k8zeZ+eGtkctCGkviNGFJvLly9TLrjgyK1gyTc590wle4Q5sQYM 6zDNdr5jAw3bjm7BhUYCtV+A0XV2iccTELp+tMudtW0S1G302RHGUQss8g6//+g12MnzLfxk28ec xWMXOWKVDNpZCBAXqjNEYAsuei8+eLBu9I4dZ7+Um1tXo2kDb1SAQTR65IBphl9XFPtFdDqCGYVp MgsqFQRb35448b4n3RFTDgwM5ABMHDJNErLHzW3zo+xIQmOBsD1egAKTwvSWPmAgqN5cB+DqwLgz CKyuGoEO1WW6bt2fm3tVTNOCl8RiDXvBpJ2alr5twoRS8u0nbCkHBmwZwXn6V7AzJ5y8cweitkUA xBkhqY7xcC36T9ijr0Wj1lhNG/Ar0ySV6hocMs5gyShdP8YikcPThw59bfOYMS8T6gm3lAMD+k/h XI2zpaNhTGRdCoCQ+g8jDclVBQaYbMDscJidDDsxCWF/D+Nzx36AJVvAwKcmT173YCKzduyTMmB2 7Jh9PQzcFHieqYZBTiVhPYqvieyIj7wE2NHwF1yEYPZMTQucZhhHH8bYmqr6X0Hswk2zMc6ojuIQ qF6A1lx+ww33z+sLIO49fQIGlp4XFRVb27fPHcFYWh5TYpdih78l1AAWTRQng5o4W+AXmMoHkEAf 6Xr96vR0/hDYMQJebaVhNusWsx9iFr9LVdU4KN0FtRzMsuGK9aeSAYXu7QQMjGfg+PHDzfn5v2y1 fB1mGT687rrt2wsL4R2Q2fqDiMwdd6wb9U5POMNu10U8kr/T1BAZBldVM8GS8MuGEV6uaZnXNzU1 /Zdz/h4CLc2wGp5WbPU8IQYMQ/AFRnUvMtIkRpApqm99Tc38y/Lzyw72FaBOwDQ1sTWqOnRwefnc KaFQRTcWVB2G+scYuDpY/2NysY4LkqvuSomIFdSQxzj9ACS5Ha+ieAFK5ChALoVtuQclhHPxPWwY A/Zw3nAYAP4O984gL0dDUMzREzQmizCAOMTm9aRKc1MCTHX1ghxNi0wCC7JPOkl/uKZm3msQAkGV vhbRqEOH6ur5wzTNugXXyCBKIByZe1YdCuo4z8I9jW8jXlkDFXwesF4BIKqgftvhjr8iRMa5sRgl hcpF773H9GHDzPthyCOcB86SKnoi9ZS/g3kYgxeANZVgzV/7Ak47xnAensV5EAkW1TYyrsairpaD Nly3bVtoN+KTU4Swb8IuZkmXmmhTwaoMCuU36br9C8zxZYAaDofFrkDAADDWy4g9PiCwiRawE7nn nFN3aiQSvJexOjDgeB7szbUyFWgbHHY3vxPNImnS+5xhd1Al9SwZMlMeI/MZaqD/RYgOL5LhczTO lBPtnnu3DL/hSSqQi3wkRPoO2NBsw4jd4fPpi0zTi9n41/Pz79uybdvcFaoaWIEUwQ/P9iUhGgcb hjYYu55XUxMCq7KmgHEJgEPhgt5kmr66RLeuY792wADlTBmGt+/WGnA5itPDXGr899ZdBfPI/T4N Vrzi8QS32nYMdqkBYHlPh+vdjDmBsHr9+vULAJRxiL6RywYwp4GZf+TcfAaVunEFBeVTt22bB5uc eYNMQmUaEd862j68ZAxHlTzYpFcPHvQeShqYqqrZV4EV42D4TmDgumYK4pd4oUhBMsYBOMUlKi0w BuHXcC6WIi6h71grjRGl/MdHwRqAyAZ7noGqnk75kkzwxPlw2Y/6/bYXke8ugDOxoODeyVu3zr8P avljAti2I84cSAOoJIHKneYnY67r4WeRZRdSSJEUMJs3h0Kg+N1wnZ7O9Y2eh0Zi5+ww7TRswL14 PxOCTCDK0yLx/iYM7wGAcn7H/EnmRsRQKk34R0phdSfytSBmWpqBOMmHa2o2Rt/5wAPzr7jttrKf VFeHkAB6fwbVEjSvbR9HyYKXwqCvhwn4a339ofGh0INtaxO9xieuSvw0TA5QyDsnbq/IoILW/8Fu 7YLx/O3w4ZmPvftuw0yoyARyq2AOwFLe0HVx1OMxbCotdOduW3Mr7qgyXhDavhZqRrUTZMCZOUKE n6mqmj/j1lvLigHSE3AES8C6IEDcgHXH0B/rsdYlCwqhKCoqQusyMz0ze+dlSI8dUPbEYurNpBtC WKPGjCk29u+fj0pdGH5c85CAAIlcDfIdhbuGvfP2uepJ9svdGLsB9/wnFmus5FybhvWlgUODsAk7 q6pufxTQbTUMezHnTWNwz9Vg5020EXiNRWS+FmrU1gj1njG5uRkz9+2LMo+nNUDrOArFIKZJWa4b pJGXCb8J9VgohLIS9mOKbYffx4KewIL2b9o0/zXYiTFkyPHikUgY6b8nalnc3xVjSOXI5khQ0sCQ 6G90vREVu+CpmsYgsJZG9gS1WMemKEp6HhiaJ41wlqPGFFORSgP8K4YNc8Lq5IAZPNhgr79uUomx S1TJEJLRzMiIWk1NsvQmBdarsMhSVUWu5FxTtgAUBzlExI+qKsNOkkpwDyLohg0bfrpfVbVLyY60 bbKk0LQHPYegDkt2aEksZjzi9QYBDIHi1Wy7NWmkIxIwkmZEIGX/G0yi2gxxE2tT/gmQahActp+k 13yBKv3+9xTBEiik/21HkOk/duIvKE+uAnA3YGcnksGELaJQHaU1Tx7iEeyURrbjDfduyxKgerQY blNBsHZB/PpGjA9gyKWTcBQJE/Oiz2P+J1HGXCk9mHWRpolFMK6Z0hgTK9rbPckMvR7rmCyQTqED 3JjKDeOTgzNnbsTakm/ikUd8bP16ne3cabD0dJc1EhRQGul+dNP06eW/raz86VCPR5lIxhACQgCO MqDxGNL8a7BrphB8n7ucjz/2vj14cPMb2L0LAeDIysoFuXPmlG5dv/72m8CKa9wNQGjwEID+NVj5 c1xDDEXVN/93yDMZhhtZd8Vkcunek2G/NjU22hNCodKWuZOHRI4gRo7k7JATBrV6DOlmI9hJC97G /wsEX1cKYbxIC5e77T0Z4fvAzEzvd8JhHQmgUtfY6G3JZKFSxrp1hU+iO4BJ05BqrMRNEz7+OD1v yJDIAkw7GvHLLzFeA1gFj6LmuEFkq3fqObKmCByJ7IVpaeHFsG1zXDVOGTBXXmmwt94yUZ13VUku CJHqJnK7MKxZhmFcduxYxtZAIAwLqCEjprpsbFFTU/NTABHeR98fChU7OQTYcTEEPyQEQw4Umwfa AxjftysrCyuCwcid06eX3l1ZOf8MjPtdjLUEhhWniW4pM1GxpOrHo/SpwSCD6rGejw8SHTreT7zz jvFuIOA9282USZ+lgfP8ibEYIlGGUiIbHYmw8sxM5e8QCH3JQ3iQTNo3kceCWr0IQC5ETPEzxCrX AaiNM2eWzli7thARqAXvFEOQ55ujadGplZV31OMa3K53gDxr7l3sJI9fnMN7cgA4bVTK6+oYWeeU NuHz2X+AGz271fCSBaYaa/jUI0c+ujMn57RbYCu+SlStqFjwFvrF+zoVfTBLpxs+hOdC9i2G0jgA 4lrQ2wuGfE+I5rG2nTZJUeDvWdogjDWIKvkSXKnCiTfqSwdq0VKwee/hwx8hPHjQHSjxYRLoKUBl 2A42q218gUkpXpg3aNAZ/4Cg5FmcHcHJ4R/xdqPbl2IKsOoAWIMPnqHxo1OKJ04ZONC4FLGGaVne 5WDZuTLVaFuo7w0gcQgdbxT9F8YsdlU3ARn71EVEo+zPMrgjlyhzLhlrcITjxmjYkIH4HCwvX0xx yQs4n3Eq9zJJdPS8Fmw4T95H48iTPdxbg3QADBGKTBxT0Zz5/tbfoNBKBWKG90HrT+AdclqDLzcK 9g6ka2AAHsQxLg0GPRVHj0Zw4JWGpI4qZbGHkZ88jNhkd/sCkuO5TiIPJk8NU9Gc+AdWmqN41f+N QmcfRaeOJ26n7wROuwByVEFBcaSsbOH7YMpoFJ1m3H77XRvKyhZtRC6TLUFtqx7uvb1Xma7FFmSX mqNRLz0p0e8N58vGyarqyaK6SHctXpk/h45NsrJQnHQMrGHec8/Cu1H+vK31AKw/1+s4BT/iKWJr nytzia4Qz67Ro1kuW7rfXaoxeb2RU3CkcRaxC7bjAbyoSBS3LalihpORk5bHZSCb5W6aQMnTHJCo cMn0o9lJeZ0313h2HDAOXDO8y2VY8BfoUQtpeGnBPZU6+7I0cgJOzbYZU5jYkHTkYk6yhGvv+Hza gb6M2tt7AIzxCeKYD3DjYDDAIxdAwpIBddy2E2Hi84MA41ZZU6FddKdKHVMIEAIc9ms3AsVFlJMh bUBt2EIhnCE5VL4Lj1TfWyH70l8sWlT6j5KSBaPAhFMQd+RCbOQ3ym2w/lR4tQACXLReju946E+9 QkbFqWpEVse1u8QFEEYZjlWWIaB0T0IPrFmzeCzSkv9irShpfjrNUWRMSM+M0ItKB1tKShYF4Glu Bgh7Fy5cdXlJyeKxCOI2SJZ0X9Dq3ZLjGswMDCjitLNMzLO3DSjOkIWFq//cu7GT793loT7qI1Qy uBnvwZKSJVvAFjzhSGuX6pV8I1CcUDgfL9R12A/AGrIdj4Itryc/fvIjdPe0wyXSrnCKaPGAIH1O lQqRHbWpIFWyZMnq38RFaHnEK3mRUjNCJ2BWrVqKIxBlcmt4706UCqY45QKcFlizFi9eXZUaEfpn lHbArFy5uBBHfSHJkD6fVfWwUgKGnjbktf0jTupGbQFm5cqlC2H4SvoPFLloOi9CbQeJqWPsP7PN AaaoaNkP4aodUKQKpUJtupYZRp3+MwSPvn+2mygqWvoDLPaBVlfcvwvGPC9hhrf7d5bkRyfG0PnM 81jw1ztn18lPIEdox8AALiR+DpyqJfRyHLF8+artuGc7MufLoE74Dwx7MgQ5szNI3amXmxucSP3o KFGhp7Ixn3Ns+5luLcYX0SYK1+xZAISnBtg4gPRtsGg8PmOHexK65TcqwFA5gNiAYrfT6GTwOcRE GFtxVGjFilWpzjr7BeBOcQwAIuFcFuG/RRidBkDNbBxq8RfwvSWWh0s/C9fw/0M2TqYU/LsL+3cc mJF4p/L/vhUrilNewe8XJDoM+j/RFirmLezg3QAAAABJRU5ErkJggg== ------=_NextPart_000_2163B_01D839EC.9CA936B0--